| Literature DB >> 34059574 |
Akira Minematsu1, Yasue Nishii1, Susumu Sakata2.
Abstract
OBJECTIVE: This study aimed to explore optimal conditions of whole-body vibration (WBV) for improving bone properties in aged rats.Entities:
Keywords: Aged Rats; Bone Mechanical Strength; Cortical Bone Geometry; Trabecular Bone Microstructure; Whole-Body Vibration
Mesh:
Substances:
Year: 2021 PMID: 34059574 PMCID: PMC8185260
Source DB: PubMed Journal: J Musculoskelet Neuronal Interact ISSN: 1108-7161 Impact factor: 2.041
Body weight, food intake, muscle weight, bone length, bone weight and ash weight of femurs in all groups of Experiments I and II.
| Muscle weight (mg/BW) | Bone weight (mg/BW) | |||||||
|---|---|---|---|---|---|---|---|---|
| Final BW (g) | Soleus | EDL | Bone length (mm) | Wet | Dry | % Ash weight | ||
| Experiment I | Baseline | 500.3±49.1 | 0.301±0.034 | 0.340±0.023 | 41.5±1.3 | 2.61±0.10 | 1.82±0.06 | 63.3±1.9 |
| CON | 493.8±22.5 | 0.310±0.020 | 0.341±0.016 | 41.2±0.8 | 2.54±0.14 | 1.79±0.09 | 62.5±2.3 | |
| 15 Hz | 469.8±31.9 | 0.317±0.021 | 0.356±0.024 | 41.4±1.4 | 2.58±0.09 | 1.79±0.06 | 61.5±2.0 | |
| 30 Hz | 471.6±22.0 | 0.306±0.022 | 0.335±0.022 | 41.1±1.4 | 2.57±0.10 | 1.82±0.13 | 62.1ω1.8 | |
| 45 Hz | 473.1±33.0 | 0.311±0.019 | 0.340ω0.015 | 40.9±0.7 | 2.60±0.18 | 1.77±0.12 | 63.9±1.8 | |
| 60 Hz | 469.2±48.5 | 0.302±0.024 | 0.343±0.028 | 40.9±1.5 | 2.62±0.35 | 1.85±0.21 | 63.1±2.4 | |
| 90 Hz | 466.0±39.8 | 0.325±0.019 | 0.351±0.015 | 41.4±1.2 | 2.66±0.12 | 1.84±0.10 | 62.8±2.2 | |
| Experiment II | 0.3 g (2.9m/s2) | 479.9±22.4 | 0.291±0.033 | 0.340±0.021 | 41.1±0.7 | 2.66±0.15 | 1.92±0.14 | 61.3±1.6 |
| 0.5 g (4.9m/s2) | 473.1±33.0 | 0.311±0.019 | 0.340±0.015 | 40.9±0.7 | 2.60±0.18 | 1.76±0.12 | 63.9±1.8 | |
| 0.7 g (6.9m/s2) | 488.7±35.9 | 0.311±0.021 | 0.350±0.018 | 41.3±1.2 | 2.63±0.16 | 1.93±0.17 | 62.2±3.1 | |
| 1.0 g (9.8m/s2) | 468.7±21.1 | 0.325±0.025[ | 0.353±0.013 | 41.7±0.5[ | 2.80±0.16[ | 1.90±0.14 | 62.9±1.9 | |
Significantly different from the 0.3 g WBV group (p<0.05).
Significantly different from the 0.5 g WBV group (p<0.05).
Significantly different from the baseline, CON and 0.5 g WBV groups (p<0.05). Data are expressed as mean ±SD. Each group is comprised of 5-7 animals. CON, age-matched control; BW, body weight; EDL, extensor digitorum longus.
Trabecular and cortical bone mineral parameters of femurs in all groups of Experiments I and II.
| Trabecular bone | Cortical bone | |||||
|---|---|---|---|---|---|---|
| TMD (mg/cm3) | BMC (mg) | vBMD (mg/cm3) | TMD (mg/cm3) | BMC (mg) | ||
| Experiment I | Baseline | 1018.2±39.2 | 4.96±2.50 | 220.2±80.4 | 1568.5±10.0 | 11.4±1.0 |
| CON | 1038.1±24.3 | 3.28±0.32 | 172.7±21.3 | 1557.4±15.9 | 10.9±0.6 | |
| 15 Hz | 1023.0±33.7 | 2.53±0.34[ | 140.3±25.9 | 1587.3±18.3[ | 10.6±0.5 | |
| 30 Hz | 1033.6±52.3 | 2.81±1.01 | 159.5±60.3 | 1569.4±10.7 | 10.7±0.5 | |
| 45 Hz | 1037.6±27.2 | 3.24±0.97 | 175.6±52.6 | 1558.4±15.2 | 10.8±0.6 | |
| 60 Hz | 1043.7±15.0 | 2.97±0.88 | 164.9±27.7 | 1558.8±17.5 | 10.9±1.0 | |
| 90 Hz | 1036.9±18.7 | 2.75±0.66 | 154.8±32.0 | 1567.4±17.3 | 10.7±0.6 | |
| Experiment II | 0.3 g (2.9m/s2) | 1028.8±15.1 | 3.54±1.10 | 176.0±35.8 | 1568.8±22.9 | 11.3±1.0 |
| 0.5 g (4.9m/s2) | 1037.6±27.2 | 3.24±0.97 | 175.6±52.6 | 1558.4±15.2 | 10.8±0.6 | |
| 0.7 g (6.9m/s2) | 1030.6±20.4 | 3.20±0.54 | 171.3±25.7 | 1592.8±4.5[ | 12.0±1.0 | |
| 1.0 g (9.8m/s2) | 1021.0±38.2 | 3.13±0.68 | 160.8±37.9 | 1600.3±10.1[ | 11.5±0.6 | |
Significantly different from the CON group (p<0.05).
Significantly different from the baseline, CON and 0.5 g WBV groups (p<0.05). Data are expressed as mean±SD. Each group is comprised of 5-7 animals. CON, age-matched control; TMD, tissue mineral density; BMC, bone mineral content; vBMD (=BMC/ tissue volume), volume bone mineral density.
Figure 1Trabecular bone microstructure of femurs in all groups. *Significantly different from the CON group (p<0.05). .
Cortical bone geometry of femurs in all groups of Experiments I and II.
| CV (mm3) | MV (mm3) | CV/AV (%) | Ct.Th (mm) | Cr.Ar (mm2) | Ps.Pm (mm) | Ec.Pm (mm) | Ct.Po (%) | ||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 7.13±0.68 | 6.14±0.64 | 53.6±2.3 | 0.63±0.05 | 7.13±0.68 | 13.3±0.5 | 10.4±0.6 | 0.44±0.15 | |
| Experiment I | CON | 6.86±0.40 | 6.28±1.01 | 52.3±4.8 | 0.59±0.05 | 6.87±0.40 | 13.4±0.4 | 11.1±0.8 | 0.53±0.19 |
| 15 Hz | 6.58±0.35 | 6.24±0.98 | 51.4±3.5 | 0.58±0.04 | 6.58±0.34 | 13.2±0.6 | 10.7±1.3 | 0.44±0.09 | |
| 30 Hz | 6.68±0.34 | 6.47±0.99 | 50.9±4.3 | 0.58±0.05 | 6.69±0.34 | 13.3±0.4 | 11.0±1.0 | 0.48±0.15 | |
| 45 Hz | 6.82±0.33 | 5.91±0.67 | 53.5±3.4 | 0.61±0.04 | 6.83±0.34 | 13.2±0.3 | 10.6±0.8 | 0.54±0.08 | |
| 60 Hz | 6.82±0.51 | 6.16±0.52 | 52.4±2.6 | 0.60±0.04 | 6.82±0.52 | 13.2±0.4 | 10.9±1.0 | 0.52±0.06 | |
| 90 Hz | 6.68±0.32 | 6.44±0.72 | 50.9±2.9 | 0.58±0.03 | 6.69±0.32 | 13.4±0.5 | 10.9±0.8 | 0.47±0.05 | |
| Experiment II | 0.3 g (2.9m/s2) | 7.10±0.62 | 6.29±0.77 | 53.0±4.4 | 0.61±0.04 | 7.11±0.62 | 13.5±0.7 | 11.0±1.1 | 0.41±0.16 |
| 0.5 g (4.9m/s2) | 6.82±0.33 | 5.91±0.67 | 53.5±3.4 | 0.61±0.39 | 6.83±0.34 | 13.2±0.3 | 10.6±0.8 | 0.54±0.08 | |
| 0.7 g (6.9m/s2) | 7.43±0.67 | 5.62±0.97 | 56.9±4.9 | 0.67±0.06 | 7.44±0.68 | 13.3±0.6 | 10.3±1.2 | 0.50±0.17 | |
| 1.0 g (9.8m/s2) | 7.07±0.44 | 6.91±0.87 | 50.6±4.4 | 0.60±0.06 | 7.09±0.44 | 13.7±0.3 | 11.3±1.1 | 0.38±0.09 |
Data are expressed as mean ±SD. Each group is comprised of 5-7 animals. CON, age-matched control; CV, Cortical bone volume; MV, Medullary volume; CV/AV, Cortical bone volume fraction; Cr.Th, Cortical bone thickness; Cr.Ar, Cortical bone sectional area; Ps.Pm, Periostea perimeter; Ec.Pm, Endocortical perimeter; Ct.Po, Cortical porosity.
Figure 2Maximum load, break point and absorption energy in femurs of all groups. †Significantly different from the BC group (p<0.05). *Significantly different from the CON group (p<0.05). Bars indicate SD. BC, baseline control; CON, age-matched control. n=5-7.
Serum concentrations of calcium and inorganic phosphorus in all groups of Experiments I and II.
| Ca (mg/dL) | IP (mg/dL) | ||
|---|---|---|---|
| Experiment I | Baseline | 10.4±0.2 | 4.0±0.4 |
| CON | 10.4±0.2 | 4.3±0.2 | |
| 15 Hz | 10.6±0.4 | 4.8±0.9 | |
| 30 Hz | 10.3±0.2 | 4.1±0.3 | |
| 45 Hz | 10.3±0.2 | 4.3±0.3 | |
| 60 Hz | 10.4±0.2 | 4.3±0.5 | |
| 90 Hz | 10.4±0.4 | 4.1±0.7 | |
| Experiment II | 0.3 | 10.4±0.1 | 4.1±0.1 |
| 0.5 | 10.3±0.2 | 4.3±0.3 | |
| 0.7 | 10.5±0.2 | 4.1±0.2 | |
| 1.0 | 10.4±0.2 | 4.0±0.3 | |
Data are expressed as mean ± SD. Each group is comprised of 5-7 animals. CON, age-matched control; Ca, calcium; IP, inorganicphosphorus.
Figure 3Serum levels of osteocalcin and TRACP-5b, and osteocalcin/TRACP-5b ratio in all groups. A, serum levels of osteocalcin; B, serum levels of TRACP-5b; C, ratio of osteocalcin to TRACP-5b. Bars indicate SD. TRACP-5b, tartrate-resistant acid phosphatase-5b; BC, baseline control; CON, age-matched control. n=5-7.